- Fund Type: Open-End Fund
- Objective: Region Fund-Euro Countries
- Asset Class: Equity
- Geographic Focus: Euro Countries
AMF Aktiefond Euroland
+ Add to WatchlistEUROPAF:SS
117.18 SEK 0.49 0.42%As of 00:59:30 ET on 05/24/2013.
Snapshot for AMF Aktiefond Euroland (EUROPAF)
| Year To Date: | - | 3-Month: | +9.20% | 3-Year: | +6.37% | 52-Week Range: | 84.20 - 119.22 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +4.52% | 1-Year: | +33.01% | 5-Year: | -0.69% | Beta vs FTAW14: | 0.78 |
Fund Profile & Information for EUROPAF
AMF Aktiefond Euroland is an open-end fund established in Sweden. The Fund's objective is long-term capital appreciation. The Fund invests in equities listed in any of the EMU countries. The Fund can also invest a maximum of 20 percent in Euro denominated debt-instruments.
| Inception Date: | 04-30-1999 | Telephone: | +46-8-696-3100 |
|---|---|---|---|
| Managers: | ANDERS FAGERLUND | ||
| Web Site: | www.amf.se | ||
Fundamentals for EUROPAF
| NAV | (on 2013-05-24) 117.18 |
|---|---|
| Assets (M) | (on 2012-01-31) 1,509.50 |
| Fund Leveraged | N |
| Minimum Investment | 0.00 |
| Minimum Subsequent Investment | 0.00 |
Dividends for EUROPAF
| Dividend Type | Income |
|---|---|
| Dividend Frequency | Annual |
| Last Dividend Net | (on 2012-06-04) 3.91 |
| Dividend Yield (ttm) | 3.33 |
Fees & Expenses for EUROPAF
| Front Load | 0.00 |
|---|---|
| Back Load | 0.00 |
| Current Mgmt Fee | 0.40 |
| Redemption Fee | 0.00 |
| 12b1 Fee | - |
| Expense Ratio | 0.40 |
Top Fund Holdings for EUROPAF
Filing Date: 03/31/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Novartis AG | 213,000 | 98,628,407 | 4.937% |
| Sanofi | 109,284 | 72,260,527 | 3.617% |
| Royal Dutch Shell PLC | 308,000 | 65,219,005 | 3.265% |
| HSBC Holdings PLC | 933,000 | 64,965,730 | 3.252% |
| BNP Paribas SA | 170,926 | 57,737,043 | 2.890% |
| BASF SE | 92,830 | 53,265,462 | 2.666% |
| Xstrata PLC | 407,000 | 43,281,319 | 2.167% |
| Rexel SA | 299,500 | 42,725,388 | 2.139% |
| Vodafone Group PLC | 2,210,000 | 40,838,754 | 2.044% |
| GlaxoSmithKline PLC | 258,000 | 39,341,389 | 1.969% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page